A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole

A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole

Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...

Full description

Bibliographic Details
Main Authors:	Mohsin Hamid, Bilal Lashari, Irfan Ahsan, Ida Micaily, Usman Sarwar, Joseph Crocetti
Format:	Article
Language:	English
Published:	Greater Baltimore Medical Center 2018-05-01
Series:	Journal of Community Hospital Internal Medicine Perspectives
Subjects:	Methotrexate trimethoprim-sulfamethoxazole deadly drug interaction folinic acid rescue pancytopenia
Online Access:	http://dx.doi.org/10.1080/20009666.2018.1466598

Similar Items

A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim–Sulfamethoxazole-Induced Pancytopenia
by: Khalid Sawalha, et al.
Published: (2021-06-01)

An unexpected cause of hyponatremia in a cancer patient: Trimethoprim-sulfamethoxazole
by: Dilsa Mizrak, et al.
Published: (2016-04-01)

Psychosis resulting from trimethoprim-sulfamethoxazole treatment for preseptal cellulitis
by: Kashif M Iqbal, et al.
Published: (2022-01-01)

Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
by: Seema U. Nayak, et al.
Published: (2013-12-01)

Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy
by: Nonso Osakwe
Published: (2023-01-01)

Biofilm formation in trimethoprim/sulfamethoxazole-susceptible and trimethoprim/sulfamethoxazole-resistant uropathogenic Escherichia coli
by: Nitis Smanthong, et al.
Published: (2015-06-01)

Life-Threatening Hyperkalemia following Low-Dose Trimethoprim-Sulfamethoxazole: A Case Report
by: Hikaru Katagiri, et al.
Published: (2023-05-01)

A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis
by: Alireza Lashay, et al.
Published: (2017-06-01)

Trimethoprim/sulfamethoxazole‐induced methemoglobinemia in pediatric patient: A case report
by: Sultan Alotaibi, et al.
Published: (2023-03-01)

Efficacy of using trimethoprim‐sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia
by: Naoto Azuma, et al.
Published: (2019-09-01)

Sulfamethoxazole and Trimethoprim Degradation by Fenton and Fenton-Like Processes
by: Antover Panazzolo Sarmento, et al.
Published: (2020-06-01)

The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
by: Sato T, et al.
Published: (2022-08-01)

Clinical Characteristics, Diagnosis, and Management of Aseptic Meningitis Induced by Trimethoprim-Sulfamethoxazole
by: Fan Z, et al.
Published: (2023-09-01)

Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole
by: G. Kouklakis;, et al.
Published: (2007-01-01)

Identification of physical interaction between trimethoprim and sulfamethoxazole by contact method kofler and crystallization reaction
by: Erizal Zaini, et al.
Published: (2010-01-01)

An outbreak of trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia meningitis associated with neuroendoscopy
by: Ching-Hsun Wang, et al.
Published: (2014-01-01)

Analysis on Prophylaxis of Pneumocystis Carini Pneumonia by Trimethoprim-Sulfamethoxazole in Patients with Autoimmune Diseases
by: QUE Yongtu, et al.
Published: (2023-01-01)

Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients
by: Nadine Nsiangani Lusambo, et al.
Published: (2023-10-01)

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
by: Yasutaka Mochizuka, et al.
Published: (2022-01-01)

Repeated daily dosing of weekly methotrexate therapy causing multiorgan toxicity: a case report
by: Emma Davey, et al.
Published: (2023-12-01)

Risk factors for hospital acquisition of trimethoprim–sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study
by: Ching-Hsun Wang, et al.
Published: (2017-10-01)

The efficacy of trimethoprim-sulfamethoxazole treatment in children with acute bloody diarrhea
by: Selvi Nafianti, et al.
Published: (2007-02-01)

Clinical features, risk factors, diagnosis, and treatment of trimethoprim-sulfamethoxazole-induced hypoglycemia
by: Chunjiang Wang, et al.
Published: (2023-02-01)

Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
by: Sandawana William Majoni, et al.
Published: (2018-01-01)

Investigation on the Usefulness of Sulfamethoxazole Trimethoprim Combination Small Tablets in Pediatric Pharmacotherapy: A Single Center Observational Study Using a Questionnaire
by: Jumpei Saito, et al.
Published: (2022-10-01)

Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection
by: Hui Qi, et al.
Published: (2023-06-01)

Severe hypoglycemia during pneumocystis pneumonia treatment associated with trimethoprim–sulfamethoxazole use in a patient on peritoneal dialysis
by: Arata Hibi, et al.
Published: (2017-11-01)

Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole
by: Jun Won Park, et al.
Published: (2019-09-01)

A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis
by: Mayer Falcon, et al.
Published: (2019-03-01)

Development of chromatographic methods for analysis of sulfamethoxazole, trimethoprim, their degradation products and preservatives in syrup
by: Perović Ivana, et al.
Published: (2014-01-01)

Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report
by: J. A. A. van Asperdt, et al.
Published: (2021-08-01)

Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole/trimethoprim: a retrospective observational study
by: Yuki Shimizu, et al.
Published: (2022-08-01)

A fatal case of disseminated nocardiosis due to Nocardia otitidiscaviarum resistant to trimethoprim–sulfamethoxazole: case report and literature review
by: Mazin Barry, et al.
Published: (2022-05-01)

Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label
by: Wei-I Lee, MBBS, FRACP, et al.
Published: (2024-01-01)

Investigation of Susceptibility of Methicillin Resistant Staphylococcus aureus Strains to Fusidic Acid and Trimethoprim-Sulfamethoxazole with Disc Diffusion Method
by: Serap İSKENDER, et al.
Published: (2007-09-01)

Preliminary Study on the Combination Effect of Clindamycin and Low Dose Trimethoprim-Sulfamethoxazole on Severe Pneumocystis Pneumonia After Renal Transplantation
by: Zhun-Yong Gu, et al.
Published: (2022-05-01)

Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates
by: Branko Jovčić, et al.
Published: (2017-12-01)

Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection
by: Katherine Fu, et al.
Published: (2023-06-01)

Genetic algorithm-based wavelength selection in multicomponent spectrophotometric determination by PLS: Application on sulfamethoxazole and trimethoprim mixture in bovine milk
by: Givianrad Hadi Mohammad, et al.
Published: (2013-01-01)

Evolution of trimethoprim/sulfamethoxazole resistance in Shewanella algae from the perspective of comparative genomics and global phylogenic analysis
by: Liu Chia-Wei, et al.
Published: (2022-12-01)